Production cell line enhancers
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsGang CHEN, Darya BURAKOV, Dipali DESHPANDE
Life of this patent
Estimating the term…
Loading patent…
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsGang CHEN, Darya BURAKOV, Dipali DESHPANDE
Estimating the term…
The present invention relates to discovery of the ectopic expression of EDEM2 in a production cell to improve the yield of a useful multi-subunit protein. Thus, the present invention provides for production cell lines, such as the canonical mammalian biopharmaceutical production cell—the CHO cell, containing recombinant polynucleotides encoding EDEM2. Also disclosed is a production cell containing both an EDEM2-encoding polynucleotide as well an XBP1-encoding polynucleotide. Improved titers of antibodies produced by these cell lines are disclosed, as well as the improved cell densities attained by these cells in culture.
An isolated polynucleotide comprising a nucleotide sequence, which encodes an EDEM2, a multi-subunit protein, and operably linked to a promoter, wherein the EDEM2 comprises an amino acid sequence that is at least 92% identical to SEQ ID NO:1.
A cell-line comprising clonally-derived constituent cells comprising (1) an EDEM2-encoding polynucleotide, (2) an antibody heavy chain-encoding polynucleotide, and (3) an antibody light chain-encoding polynucleotide.
Dependencies are inferred from the claim text.